Evidence map›Paper›PMID 26366219›Full record

ArticleJournal of Cancer2015

Staurosporine Induced Apoptosis May Activate Cancer Stem-Like Cells (CD44(+)/CD24(-)) in MCF-7 by Upregulating Mucin1 and EpCAM.

Na Zhou, Rong Wang, Yizhuang Zhang, Zhen Lei, Xuehui Zhang, Ruobi Hu, Hui Li, Yiqing Mao, Xi Wang, David M Irwin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Role of the Extracellular Matrix in Cancer Stemness.Frontiers in cell and developmental biology · 2019
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Na Zhou1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Rong Wang1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Yizhuang Zhang1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Zhen Lei2. Beijing N&N Genetech Company, Beijing, 100082, China;
Xuehui Zhang1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Ruobi Hu1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Hui Li1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Yiqing Mao1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Xi Wang1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
David M Irwin1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China; ; 3. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Gang Niu2. Beijing N&N Genetech Company, Beijing, 100082, China;
Huanran Tan1. Department of Pharmacology, Peking University, Health Science Center, Beijing 100191, China;
Peking University · CNAnnoroad Gene Technology (China) · CNUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant tumors recur after chemotherapy. A small population of cancer stem-like cells within tumors is now generally considered the prime source of the recurrence. To better understand how cancer stem-like cells induce relapse after fractionated chemotherapy, we examined changes in the CD44(+)/CD24(-) cancer stem-like cells population and behavior using the breast cancer cell line MCF-7. Our results show that apart from an increase in the CD44(+)/CD24(-) population, proliferation and clone formation, but not migration, were enhanced after recovery from apoptosis induced by two pulses of staurosporine (STS). The distribution of cells in the cell cycle differed between acutely induced apoptosis and fractionated chemotherapy. Sorted CD44(+)/CD24(-) stem-like cells from MCF-7 cells recovered from STS treatment possessed greater proliferation abilities. We also observed that mucin1 (MUC1) and Epithelial cell adhesion molecule (EpCAM) were up-regulated in abundance coincidently with proliferation and clone formation enhancement. Our findings suggest that fractionated chemotherapy induced apoptosis could stimulate cancer stem-like cell to behave with a stronger malignant property than cancer cells themselves and MUC1 and EpCAM are important factors involving in this process. By demonstrating changes in cancer stem cell during chemotherapy and identifying the crucial factors, we potentially can target them, to eradicate tumors and overcome cancer relapse.

Indexed as

apoptosiscancer stem cellschemotherapyEpCAMmucin1

Identifiers

PMID26366219
PMCPMC4565855
OpenAlexW2400721334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.